Skip to main content

COVID-19 Advisory: Visitor restrictions are in place for all Phoenix Children’s locations. Masks are required for all visitors and for patients ages 2+. For more information, visit our COVID-19 Resource Center.

David F. Carpentieri, MD

Edit Profile

Section Chief of Clinical Chemistry, Therapeutic Drug Monitoring, Point of Care Testing and Urinalysis; Medical Director, Biorepository

David F. Carpentieri, MD

Edit Profile

Section Chief of Clinical Chemistry, Therapeutic Drug Monitoring, Point of Care Testing and Urinalysis; Medical Director, Biorepository

Areas of Expertise

  • Pediatric Pathology Biorepositories Proteomics Pediatric Tumors Rare Diseases


+Education & Training

Board Certification

Pediatric Pathology; Anatomic/Clinical Pathology

Medical School / Education

Faculdade De Ciencias Medicas Da Santa Casa De Sao Paulo, Sao Paulo, Brazil


Lankenau Hospital, Thomas Jefferson University, Wynnewood, PA


(Pediatric Pathology) The Childrens Hospital of Philadelphia - Philadelphia, PA


Jackson Memorial Hospital, Miami, FL

+Academic and Professional Affiliations

Academic Affiliations

Assistant Professor of Clinical Pathology and Pediatrics, Univ. of Arizona;Assistant Professor of Pathology, Mayo Medical School; Assistant Professor in the Clinician Scholar Track in Biorepository/Pathology, Barrow Neurological Institute

Professional Affiliations

American Association for Clinical Chemistry (AACC), Children's Oncology Group (COG), Society for Pediatric Pathology (SPP), International Society for Biological and Environmental Repositories (ISBER); United States-Human Proteome Organization (US-HUPO)


  • Awards and Honors: 2010-2014 Best Doctors in America

+Research & Publications

Shusterman S, Grupp SA, Barr R, Carpentieri D, Zhao H, Maris JM. The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease. Clin Cancer Res 2001 Apr;7(4):977-84.

Zhang Q, Raghunath PN, Xue L, Majewski M, Carpentieri DF, Odum N, Morris S, Skorski T, Wasik MA. Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma. J Immunol 2002 Jan 1;168(1):466-74.
Carpentieri DF, Nichols K, Chou PM, Matthews M, Pawel B, Huff D. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors. Mod Pathol 2002 Oct;15(10):1080-6.

Fleming MD, Pinkus JL, Fournier MV, Alexander SW, Tam C, Loda M, Sallan SE, Nichols KE, Carpentieri DF, Pinkus GS, Rollins BJ. Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosis. Blood 2003 Apr 1;101(7):2473-5. Erratum in: Blood 2003 Nov 15;102(10):3477.

Carpentieri DF, Wherli S, Pawel B, Henretig FM. Potential applications of proton nuclear magnetic resonance spectroscopy in the diagnosis and management of methanol intoxication in the pediatric population. Pediatr Emerg Care 2003 Jun;19(3):178-180.

Tang XX, Robinson ME, Riceberg JS, Kim DY, Kung B, Titus TB, Hayashi S, Flake AW, Carpentieri D, Ikegaki N. Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma. Clin Cancer Res 2004 Sep 1; 10(17):5837-44.

Carpentieri DF, Qualman SJ, Bowen J, Krausz T, Marchevsky A, Dickman PS; Cancer Committee, College of American Pathologists. Protocol for the examination of specimens from pediatric and adult patients with osseous and extraosseous ewing sarcoma family of tumors, including peripheral primitive neuroectodermal tumor and ewing sarcoma. Arch Pathol Lab Med 2005 Jul; 129(7):866-73.

Fortin SP, Ennis MJ, Savitch BA, Carpentieri D, McDonough WS, Winkles JA, Loftus JC, Kingsley C, Hostetter G, Tran NL. Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function. Mol Cancer Res. 2009 Nov;7(11):1871-81.

Campbell LD et al. 2012 best practices for repositories collection, storage, retrieval, and distribution of biological materials for research international society for biological and environmental repositories (ISBER). Biopreserv Biobank. 2012 Apr;10(2):79-161.

Chakravadhanula M, Tembe W, Legendre C, Carpentieri D, Liang WS, Bussey KJ, Carpten J, Berens ME, Bhardwaj RD. Detection of an Atypical Teratoid Rhabdoid Brain Tumor Gene Deletion in Circulating Blood Using Next-Generation Sequencing. J Child Neurol. 2014 Sep 29(9). [Epub 2013, Oct 17].

VandenHeuvel KA, Carpentieri DF, Chen J, Fung KM, Parham DM. Ectomesenchymoma with embryonal rhabdomyosarcoma and ganglioneuroma, arising in association with benign triton tumor of the tongue. Pediatr Dev Pathol. 2014 May-Jun;17(3):226-30. [Epub 2014 Mar 20].

Biorepositories, proteomics, pediatric tumors, rare diseases
Share this page